SCHEMBL29428628

SCHEMBL29428628

CCCC(O)c1cccc2cccc(Br)c12

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 4/20 0.35
CNR1 P21554 2/20 0.33
CACNA2D1 P54289 1/20 0.31
CYP1B1 Q16678 1/20 0.31
KDM4E B2RXH2 2/20 0.30
NSD2 O96028 2/20 0.30
MAPT P10636 2/20 0.30
CYP11B1 P15538 1/20 0.30
CYP11B2 P19099 1/20 0.30
ALDH1A1 P00352 2/20 0.30
APP P05067 1/20 0.30
GAA P10253 1/20 0.30
HPGD P15428 1/20 0.30
SNCA P37840 1/20 0.30
HSD17B10 Q99714 1/20 0.30
CYP3A4 P08684 1/20 0.30
ALOX15 P16050 1/20 0.30
CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25324572 1.00 CNR2 (0.35) CNR2CNR1CACNA2D1CYP1B1KDM4E
SCHEMBL6684572 0.80 HTT (0.40) CYP11B1CYP11B2ALDH1A1GAACYP3A4
SCHEMBL6741649 0.80 HTT (0.40) CYP11B1CYP11B2ALDH1A1GAACYP3A4
SCHEMBL30735341 0.79 CYP11B1 (0.34) CYP11B1CYP11B2ALDH1A1
SCHEMBL15353499 0.78 PRNP (0.36) CNR2CNR1CYP11B1CYP11B2ALDH1A1
SCHEMBL2734713 0.74 ALDH1A1 (0.47) ALDH1A1GAACYP2C19
SCHEMBL506055 0.73 ALDH1A1 (0.43) CYP1B1KDM4EMAPTALDH1A1HPGD
SCHEMBL29980279 0.73 ALDH1A1 (0.43) CYP1B1KDM4EMAPTALDH1A1HPGD
SCHEMBL6745332 0.72 MAPK1 (0.33) CYP11B1CYP11B2ALDH1A1
SCHEMBL6742914 0.72 MAPK1 (0.33) CYP11B1CYP11B2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4216951-A1 KRAS G12D INHIBITORS Mirati Therapeutics, Inc. (US) 2023-08-02 EP disclosed
WO-2022066646-A1 KRAS G12D INHIBITORS Mirati Therapeutics, Inc. (US) 2022-03-31 WO disclosed